This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Particulate Processes in the Pharmaceutical Industry III

January 12th, 2011

Over 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; drying, granulation, and coating; tablet compaction; fine powder transport, mixing, and blending. These and other particulate processes are used for the large-scale manufacture of tablets and capsules as well as dry powder inhalants for public consumption. As such, efficient handling and processing of particulates is critical to meeting the stringent guidelines set by the FDA and profitable manufacture of pharmaceutical products. Failed batches can mean the loss of hundreds of thousands of dollars in revenue needed to payback the tremendous up-front investment that is inherent in drug development. A recent US-FDA report on the pharmaceutical industry estimated that worldwide cost savings from manufacturing improvements could be as high as US$ 90 billion per year.

The particulate-based manufacturing processes need to be better understood so that they can be properly designed and controlled. The last decade has seen a shift from empirical formulation efforts to an engineering approach based on a better understanding of particulate behaviours in various processes, facilitated by technological advances in computer modelling, manufacture and measurement techniques.

This conference, by bringing together researchers from industry and academia, will be showcasing and demonstrating how the latest R&D in particulate processing can be applied to pharmaceutical industrial design and optimisation as well as how they can cater to emerging regulatory needs. A combination of oral presentations, poster sessions, and workshops will demonstrate the existing expertise and establish future research needs. This will be a perfect opportunity for participants to learn more about the latest trends in particulate process in pharmaceutical unit operations as well as a chance to interact and share their experience with others. Research collaborations will be forged to meet these needs.

The PPPI-III conference will continue the tradition of previous conferences with the well balanced focuses on both fundamental research and industrial application of particulate processing. It will also expand into emerging techniques and applications. The following lists key themes for this conference:

Theme 1 - Particle Synthesis, Crystallisation, Coating and Drying

Theme 2 - Particle Packing, Granulation and Compaction

Theme 3 - Powder Flow and Dispersion, Mixing/Blending and Handling

Theme 4 - Emerging Research Techniques (e.g. numerical modelling and PAT) and Applications

Conference Organization

Organizing Committee

Chair

Prof. Aibing Yu, University of New South Wales, Australia

Co-Chairs

Prof. Hak-Kim Chan, University of Sydney, Australia

Prof. Jim Litster, Purdue University, USA

Committee Members

Prof. Rose Amal, University of New South Wales, Australia

Prof. Xiaodong Chen, Monash University, Australia

Prof. Geoffrey Evans, Newcastle University, Australia

Prof. Clive Davies, Massey University, New Zealand

Dr. Karen Hapgood, Monash University, Australia

Prof. Kunio Shinohara, University of New South Wales, Australia

Prof. Peter Stewart, Monash University, Australia

Dr. Runyu Yang, University of New South Wales, Australia

Prof. Huijun Zhao, Griffith University, Australia

International Advisory Committee

Chair

Prof. Jonathan Seville, Warwick University, UK

Co-Chairs

Prof. Todd Pugsley, University of Saskatchewan, Canada

Prof. Jenifer Curtis, University of Florida, USA

Committee Members

Prof. Mamid Arastoopour, Illinois Institute of Technology, USA

Prof. Prabir Basu, Purdue University, USA

Prof. Paolo Columbo, Parma University, Italy

Dr. Andy Clark, Novartis, USA

Prof. Alain de Ryck, École des Mines d'Albi-Carmaux, France

Prof. Warren Finlay, University of Alberta, Canada

Prof. Pierre Guigon, Université de Technologie de Compičgne, France

Prof. Paul Heng, National University of Singapore, Singapore

Prof. Hidehiro Kamiya, Tokyo University of Agriculture and Technology, Japan

Dr. Mansoor Khan, FDA, USA

Prof Chong Kook Kim, Korean Academy of Science and Technology, South Korea

Prof. Lee Kirsch, University of Iowa, USA

Prof. Hans Leuenberger, Ifiip GmbH, Switzerland

Prof. Jinghai Li, Chinese Academy of Science, China

Prof. Gaoqing (Max) Lu, University of Queensland, Australia

Prof. Fernando Muzzio, Rutgers University, USA

Prof. Tetsuya Ozeki, Nagoya City University, Japan

Prof. Judy Raper, University of Wollongong, Australia

Prof. Rex Reklaitis, Purdue University, USA

Prof. Satoru Watano, Osaka Prefecture University, Japan

Dr. Jeff Weers, Novartis, USA

Prof. Richard Williams, University of Leeds, UK

Dr. Chuan-yu (Charley) Wu, University of Birmingham, UK

Prof. Chuanbin Wu, Sun Yet Sen University, China

Prof. Peter York, University of Bradford, UK

Dr. Jimmy Yun, Nanomaterials Technology, Singapore

Prof. Zhibing Zhang, University of Birmingham, UK

Prof. Jesse Zhu, University of Western Ontario, Canada

Submission of Abstracts

Abstracts (maximum 300 words) are solicited from participants for both oral and poster presentation. The deadlines for submission of abstracts are as follows:

Abstracts for Oral Presentations: February 28, 2011

Abstracts for Poster Presentations: March 15, 2011

Abstracts should be submitted electronically following the instructions given in On-line Abstract Submission. If you encounter any problems with the submission process, contact Engineering Conferences International (ECI) at info@engconfintl.org or 1-212-514-6760.

Conference Publication

Submission of conference papers: If abstracts are accepted for oral presentation, authors are required to submit draft papers which will be included in the non-refereed conference proceeding.

Submission of final papers: Final papers should be submitted no later than one month after the conference. The papers will be reviewed and, if accepted, will be published in the special issues of selected journals, such as Powder Technology.

Key dates for oral submissions

February 28, 2011 -Submission of one-page abstracts

February, 2011 -Notice of acceptance

April, 2011 - Submission of full paper

August, 2011 - Submission of full paper for journal publication

Destination - Gold Coast

The Gold Coast is Australia's premier holiday destination and home of Gold Coast Tourist Attractions Sea World, Warner Bros. Movie World, Wet'n'Wild Water World, Australian Outback Spectacular, Paradise Country and Sea World Resort. Famous for its theme parks, stunning beaches and subtropical rainforests, the Gold Coast boasts 70 kilometers of uninterrupted coastline and 26 patrolled beaches.

Follow the roads inland from the sand and surf and a magical world unfolds. A world of lush rainforests, national parks, quiet villages and craft shops and spectacular views. Wander through the magnificent wilderness area of the Gold Coast Hinterland for the day or stay a while in a cozy mountain retreat.

Fresh seafood and contemporary Australian cuisine are the Gold Coast's specialties with over 500 restaurants to satisfy every taste. Whether you choose dining out, a canal cruise, stage show, nightclub or dinner theatre, the nightlife on the Gold Coast should not be missed. Jupiters Casino features over 100 gaming tables, 6 restaurants, 9 bars and an International Showroom featuring spectacular stage productions.

Today, winery tours, walking trails, broadwater cruises and mountain drives are just as popular as the traditional theme parks, beaches and thrill attractions. Families, couples, business delegates and solo travelers will all find an experience to suit their needs at a price to suit their budget, as the Gold Coast offers more attractions and venues than any other destination in the southern hemisphere.

A location of genuine character, the Gold Coast offers an explosion of action packed days and fun filled nights enjoyed by more than 10.5 million Australians and overseas visitors every year. For further information please visit the Very GOLD COAST website (http://www.verygoldcoast.com.au/).

Accommodation - Hotel Grand Chancellor Surfers Paradise

The conference will be held at the Hotel Grand Chancellor Surfers Paradise on the Gold Coast. Hotel Grand Chancellor Surfers Paradise is a popular destination for those companies and associations wanting to conference in the heart of Paradise. Located just a short stroll to Australia's most famous stretch of beach, the Resort adjoins the Centro shopping complex and offers convenient access to shopping, restaurants and entertainment. With a comprehensive choice of venues and meeting space, the recently refurbished conference centre now features contemporary furnishings and warm colors, inspiring new designs and concepts.

Boasting an excellent location in the heart of Surfers Paradise, Hotel Grand Chancellor offers refined accommodation and high-quality facilities, just steps away from golden beaches and the town's dynamic entertainment. Relax in comfort in one of Hotel Grand Chancellor's air-conditioned guest rooms. Each room is well-appointed with modern amenities and a private balcony for your comfort. A host of leisure facilities awaits you, including a fully equipped fitness centre and tennis courts. After burning off some energy in the outdoor pool, enjoy a relaxing sauna or Jacuzzi. Less than 5 minutes' stroll from Hotel Grand Chancellor lies one of the stunning beaches along the Gold Coast. Vibrant shopping opportunities, energetic nightlife and a wealth of water sports surround the resort, offering all you need to enjoy Surfers Paradise.

Provided by Engineering Conferences International

Citation: Particulate Processes in the Pharmaceutical Industry III (2011, January 12) retrieved 27 April 2025 from https://sciencex.com/wire-news/56290729/particulate-processes-in-the-pharmaceutical-industry-iii.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.